The Alluvi Retatrutide pre-filled research pen is designed for ease of use in controlled laboratory settings. This step-by-step guide covers everything from preparation to post-use storage for both the 20mg and 40mg formats.
Research Use OnlyThis guide is for in vitro laboratory research applications only. Alluvi Healthcare retatrutide pens are not for human consumption, clinical use, or self-administration. All use must comply with applicable UK research regulations.
What's in the Box
- 1× Pre-filled Retatrutide Research Pen (20mg or 40mg)
- Janoshik Certificate of Analysis — Batch AR0763RT4
- MSDS (Material Safety Data Sheet)
- Storage and handling guidelines
- Research information sheet
Before Use — Storage Check
- Verify the pen has been stored at 2–8°C — do not use if frozen or exposed to heat above 25°C
- Remove from refrigerator 15–30 minutes before use to allow the solution to reach room temperature
- Inspect the solution — it should be clear and colourless. Do not use if cloudy, discoloured or contains particles
- Check the seal is intact — do not use if the pen appears tampered with
Pen Setup and Priming
First Use Only — Priming
- Remove the pen cap
- Attach a new sterile needle following the needle manufacturer's instructions
- Dial the dose selector to the priming dose (typically 2 units or as specified in your protocol)
- Point the pen upwards, tap gently to move air bubbles to the top
- Press the dose button until a small drop appears at the needle tip — pen is primed and ready
Dose Setting
| Pen Format | Doses per Pen | Per Dose | Dose Range |
|---|
| Retatrutide 20mg Pen | 4 doses | 5mg | Fixed 5mg increments |
| Retatrutide 40mg Pen | 4 doses | 10mg | Fixed 10mg increments |
Injection Procedure (Research Protocol Context)
- Select appropriate subcutaneous tissue site per your research protocol
- Clean the site with an alcohol swab and allow to dry
- Pinch a fold of tissue gently between thumb and forefinger
- Insert the needle at a 45–90° angle depending on tissue depth
- Press the dose button firmly and hold for 10 seconds before withdrawing
- Release the tissue fold and withdraw the needle in one smooth motion
- Apply gentle pressure — do not rub the site
Site Rotation
For extended research protocols, rotate injection sites to avoid local tissue reactions. Common rotation patterns include alternating between different areas of the abdomen, or using multiple defined zones and moving systematically between them across successive doses.
After Use — Storage and Safety
- Replace the needle cap immediately after use and dispose of the needle in a sharps container
- Replace the pen cap and return to refrigerator at 2–8°C
- Do not freeze — freezing permanently degrades the peptide
- Used pens should be stored upright in refrigerator between doses
- Record dose, date, time and site in your research log
Troubleshooting
| Issue | Likely Cause | Action |
|---|
| No solution at needle tip when priming | Air in pen / blocked needle | Change needle, re-prime |
| Cloudy or discoloured solution | Degradation or contamination | Do not use — contact Alluvi |
| Dose button won't press | Safety lock engaged | Check pen instructions — remove safety tab |
| Leak at needle connection | Needle not fully seated | Remove and reattach needle firmly |
Technical Support
For research protocol questions, storage queries or technical support on Alluvi Healthcare products, contact our team via WhatsApp at +44 7394 241184 or email support@buyalluvi.co.uk. Real specialists, not automated systems — responses within 30 minutes during business hours.
COA VerificationVerify the authenticity of your Alluvi retatrutide batch at
verify.janoshik.com — Batch AR0763RT4, 99.38% purity confirmed.
Buy Research-Grade Retatrutide UK
Alluvi Healthcare supplies independently verified research peptides with full COA, cold chain delivery and UK-based support. Batch AR0763RT4 — 99.38% purity.
